Niemann-Pick type C2 protein mediates hepatic stellate cells activation by regulating free cholesterol accumulation

Yuh Ching Twu, Tzong Shyuan Lee, Yun Lian Lin, Shih Ming Hsu, Yuan Hsi Wang, Chia Yu Liao, Chung Kwe Wang, Yu Chih Liang, Yi Jen Liao

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In chronic liver diseases, regardless of their etiology, the development of fibrosis is the first step toward the progression to cirrhosis, portal hypertension, and hepatocellular carcinoma. Hepatic stellate cells (HSCs) are the main profibrogenic cells that promote the pathogenesis of liver fibrosis, and so it is important to identify the molecules that regulate HSCs activation and liver fibrosis. Niemann-Pick type C2 (NPC2) protein plays an important role in the regulation of intracellular cholesterol homeostasis by directly binding with free cholesterol. However, the roles of NPC2 in HSCs activation and liver fibrosis have not been explored in detail. Since a high-cholesterol diet exacerbates liver fibrosis progression in both rodents and humans, we propose that the expression of NPC2 affects free cholesterol metabolism and regulates HSCs activation. In this study, we found that NPC2 is decreased in both thioacetamide- and carbon tetrachloride-induced liver fibrosis tissues. In addition, NPC2 is expressed in quiescent HSCs, but its activation status is down-regulated. Knockdown of NPC2 in HSC-T6 cells resulted in marked increases in transforming growth factor-β1 (TGF-β1)-induced collagen type 1 α1 (Col1a1), α-smooth muscle actin (α-SMA) expression, and Smad2 phosphorylation. In contrast, NPC2 overexpression decreased TGF-β1-induced HSCs activation. We further demonstrated that NPC2 deficiency significantly increased the accumulation of free cholesterol in HSCs, increasing Col1a1 and α-SMA expression and activating Smad2, and leading to sensitization of HSCs to TGF-β1 activation. In contrast, overexpression of NPC2 decreased U18666A-induced free cholesterol accumulation and inhibited the subsequent HSCs activation. In conclusion, our study has demonstrated that NPC2 plays an important role in HSCs activation by regulating the accumulation of free cholesterol. NPC2 overexpression may thus represent a new treatment strategy for liver fibrosis.

Original languageEnglish
Article number1122
JournalInternational Journal of Molecular Sciences
Volume17
Issue number7
DOIs
Publication statusPublished - Jul 13 2016

Fingerprint

Hepatic Stellate Cells
Cholesterol
cholesterol
Chemical activation
activation
fibrosis
proteins
Proteins
Liver
liver
Liver Cirrhosis
cells
Transforming Growth Factors
progressions
Fibrosis
Thioacetamide
Phosphorylation
Carbon tetrachloride
Carbon Tetrachloride
etiology

Keywords

  • Free cholesterol
  • Hepatic stellate cells
  • Liver fibrosis
  • Niemann-Pick type C2
  • Transforming growth factor-β1

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications

Cite this

Niemann-Pick type C2 protein mediates hepatic stellate cells activation by regulating free cholesterol accumulation. / Twu, Yuh Ching; Lee, Tzong Shyuan; Lin, Yun Lian; Hsu, Shih Ming; Wang, Yuan Hsi; Liao, Chia Yu; Wang, Chung Kwe; Liang, Yu Chih; Liao, Yi Jen.

In: International Journal of Molecular Sciences, Vol. 17, No. 7, 1122, 13.07.2016.

Research output: Contribution to journalArticle

Twu, Yuh Ching ; Lee, Tzong Shyuan ; Lin, Yun Lian ; Hsu, Shih Ming ; Wang, Yuan Hsi ; Liao, Chia Yu ; Wang, Chung Kwe ; Liang, Yu Chih ; Liao, Yi Jen. / Niemann-Pick type C2 protein mediates hepatic stellate cells activation by regulating free cholesterol accumulation. In: International Journal of Molecular Sciences. 2016 ; Vol. 17, No. 7.
@article{1e68acaffb48466f9289939c130b1b7f,
title = "Niemann-Pick type C2 protein mediates hepatic stellate cells activation by regulating free cholesterol accumulation",
abstract = "In chronic liver diseases, regardless of their etiology, the development of fibrosis is the first step toward the progression to cirrhosis, portal hypertension, and hepatocellular carcinoma. Hepatic stellate cells (HSCs) are the main profibrogenic cells that promote the pathogenesis of liver fibrosis, and so it is important to identify the molecules that regulate HSCs activation and liver fibrosis. Niemann-Pick type C2 (NPC2) protein plays an important role in the regulation of intracellular cholesterol homeostasis by directly binding with free cholesterol. However, the roles of NPC2 in HSCs activation and liver fibrosis have not been explored in detail. Since a high-cholesterol diet exacerbates liver fibrosis progression in both rodents and humans, we propose that the expression of NPC2 affects free cholesterol metabolism and regulates HSCs activation. In this study, we found that NPC2 is decreased in both thioacetamide- and carbon tetrachloride-induced liver fibrosis tissues. In addition, NPC2 is expressed in quiescent HSCs, but its activation status is down-regulated. Knockdown of NPC2 in HSC-T6 cells resulted in marked increases in transforming growth factor-β1 (TGF-β1)-induced collagen type 1 α1 (Col1a1), α-smooth muscle actin (α-SMA) expression, and Smad2 phosphorylation. In contrast, NPC2 overexpression decreased TGF-β1-induced HSCs activation. We further demonstrated that NPC2 deficiency significantly increased the accumulation of free cholesterol in HSCs, increasing Col1a1 and α-SMA expression and activating Smad2, and leading to sensitization of HSCs to TGF-β1 activation. In contrast, overexpression of NPC2 decreased U18666A-induced free cholesterol accumulation and inhibited the subsequent HSCs activation. In conclusion, our study has demonstrated that NPC2 plays an important role in HSCs activation by regulating the accumulation of free cholesterol. NPC2 overexpression may thus represent a new treatment strategy for liver fibrosis.",
keywords = "Free cholesterol, Hepatic stellate cells, Liver fibrosis, Niemann-Pick type C2, Transforming growth factor-β1",
author = "Twu, {Yuh Ching} and Lee, {Tzong Shyuan} and Lin, {Yun Lian} and Hsu, {Shih Ming} and Wang, {Yuan Hsi} and Liao, {Chia Yu} and Wang, {Chung Kwe} and Liang, {Yu Chih} and Liao, {Yi Jen}",
year = "2016",
month = "7",
day = "13",
doi = "10.3390/ijms17071122",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "7",

}

TY - JOUR

T1 - Niemann-Pick type C2 protein mediates hepatic stellate cells activation by regulating free cholesterol accumulation

AU - Twu, Yuh Ching

AU - Lee, Tzong Shyuan

AU - Lin, Yun Lian

AU - Hsu, Shih Ming

AU - Wang, Yuan Hsi

AU - Liao, Chia Yu

AU - Wang, Chung Kwe

AU - Liang, Yu Chih

AU - Liao, Yi Jen

PY - 2016/7/13

Y1 - 2016/7/13

N2 - In chronic liver diseases, regardless of their etiology, the development of fibrosis is the first step toward the progression to cirrhosis, portal hypertension, and hepatocellular carcinoma. Hepatic stellate cells (HSCs) are the main profibrogenic cells that promote the pathogenesis of liver fibrosis, and so it is important to identify the molecules that regulate HSCs activation and liver fibrosis. Niemann-Pick type C2 (NPC2) protein plays an important role in the regulation of intracellular cholesterol homeostasis by directly binding with free cholesterol. However, the roles of NPC2 in HSCs activation and liver fibrosis have not been explored in detail. Since a high-cholesterol diet exacerbates liver fibrosis progression in both rodents and humans, we propose that the expression of NPC2 affects free cholesterol metabolism and regulates HSCs activation. In this study, we found that NPC2 is decreased in both thioacetamide- and carbon tetrachloride-induced liver fibrosis tissues. In addition, NPC2 is expressed in quiescent HSCs, but its activation status is down-regulated. Knockdown of NPC2 in HSC-T6 cells resulted in marked increases in transforming growth factor-β1 (TGF-β1)-induced collagen type 1 α1 (Col1a1), α-smooth muscle actin (α-SMA) expression, and Smad2 phosphorylation. In contrast, NPC2 overexpression decreased TGF-β1-induced HSCs activation. We further demonstrated that NPC2 deficiency significantly increased the accumulation of free cholesterol in HSCs, increasing Col1a1 and α-SMA expression and activating Smad2, and leading to sensitization of HSCs to TGF-β1 activation. In contrast, overexpression of NPC2 decreased U18666A-induced free cholesterol accumulation and inhibited the subsequent HSCs activation. In conclusion, our study has demonstrated that NPC2 plays an important role in HSCs activation by regulating the accumulation of free cholesterol. NPC2 overexpression may thus represent a new treatment strategy for liver fibrosis.

AB - In chronic liver diseases, regardless of their etiology, the development of fibrosis is the first step toward the progression to cirrhosis, portal hypertension, and hepatocellular carcinoma. Hepatic stellate cells (HSCs) are the main profibrogenic cells that promote the pathogenesis of liver fibrosis, and so it is important to identify the molecules that regulate HSCs activation and liver fibrosis. Niemann-Pick type C2 (NPC2) protein plays an important role in the regulation of intracellular cholesterol homeostasis by directly binding with free cholesterol. However, the roles of NPC2 in HSCs activation and liver fibrosis have not been explored in detail. Since a high-cholesterol diet exacerbates liver fibrosis progression in both rodents and humans, we propose that the expression of NPC2 affects free cholesterol metabolism and regulates HSCs activation. In this study, we found that NPC2 is decreased in both thioacetamide- and carbon tetrachloride-induced liver fibrosis tissues. In addition, NPC2 is expressed in quiescent HSCs, but its activation status is down-regulated. Knockdown of NPC2 in HSC-T6 cells resulted in marked increases in transforming growth factor-β1 (TGF-β1)-induced collagen type 1 α1 (Col1a1), α-smooth muscle actin (α-SMA) expression, and Smad2 phosphorylation. In contrast, NPC2 overexpression decreased TGF-β1-induced HSCs activation. We further demonstrated that NPC2 deficiency significantly increased the accumulation of free cholesterol in HSCs, increasing Col1a1 and α-SMA expression and activating Smad2, and leading to sensitization of HSCs to TGF-β1 activation. In contrast, overexpression of NPC2 decreased U18666A-induced free cholesterol accumulation and inhibited the subsequent HSCs activation. In conclusion, our study has demonstrated that NPC2 plays an important role in HSCs activation by regulating the accumulation of free cholesterol. NPC2 overexpression may thus represent a new treatment strategy for liver fibrosis.

KW - Free cholesterol

KW - Hepatic stellate cells

KW - Liver fibrosis

KW - Niemann-Pick type C2

KW - Transforming growth factor-β1

UR - http://www.scopus.com/inward/record.url?scp=84978516332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978516332&partnerID=8YFLogxK

U2 - 10.3390/ijms17071122

DO - 10.3390/ijms17071122

M3 - Article

C2 - 27420058

AN - SCOPUS:84978516332

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 7

M1 - 1122

ER -